Investors have been actively adjusting their stakes in The Cigna Group, a health services provider. One notable addition is Kaydan Wealth Management Inc., which acquired a new stake in the company worth around $203,000. Meanwhile, Financiere des Professionnels Fonds d’investissement inc. increased its stake by 1.1%, now owning 30,664 shares valued at $9,182,000. AustralianSuper Pty Ltd also saw a significant increase, with its position in The Cigna Group rising by 11.8% to 64,064 shares worth $19,184,000. Additionally, LVW Advisors LLC bought a new position worth $205,000, and Rosenberg Matthew Hamilton increased their stake by 16.7%.
Analysts on Wall Street have been closely monitoring The Cigna Group and its recent performance. The stock, listed under NYSE CI, traded up $3.71 on Wednesday, reaching $361.44. With a market cap of $105.67 billion, the company has shown a steady upward trend. Its fifty-day moving average stands at $331.14, while the two-hundred-day moving average is $306.54. The Cigna Group’s current ratio and quick ratio are both at 0.67, indicating a stable financial position. It has a 12-month low of $240.50 and a 12-month high of $362.89. The P/E ratio is 20.57, and the PEG ratio is 1.09. As for volatility, the stock has a beta of 0.55.
In recent news, The Cigna Group announced an increase in its quarterly dividend payment. Shareholders of record on March 6th received a $1.40 dividend, marking a positive change from the previous quarterly dividend of $1.23. This represents an annualized dividend of $5.60 and a yield of 1.55%. The Cigna Group’s dividend payout ratio (DPR) currently stands at 32.20%.
Insiders of The Cigna Group have also made significant moves. Insider Eric P. Palmer sold 1,017 shares, valued at $340,959.42, while insider SVP Hoeltzel Mary T. Agoglia sold 4,867 shares for a total transaction of $1,608,446.16. The presence of insider selling could be indicative of future trends in the stock’s performance.
The Cigna Group, along with its subsidiaries, is a prominent provider of insurance and related products and services in the United States. It offers a wide range of health services through its Evernorth Health Services segment, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions.
While The Cigna Group currently holds a “Moderate Buy” rating among analysts, there are other stocks that top-rated analysts believe are better options. To explore these top-rated stocks recommended by Wall Street’s best-performing research analysts, you can access the list provided by MarketBeat.
In conclusion, The Cigna Group has caught the attention of investors and analysts alike, with its stock trading on an upward trend. With the company’s strong financial position and recent dividend increase, it remains an attractive choice for potential investors.
